Literature DB >> 12714229

MR digital subtraction angiography in the diagnosis of meningiomas.

Kazuhiro Tsuchiya1, Shichiro Katase, Ayako Yoshino, Junichi Hachiya.   

Abstract

OBJECTIVE: MR digital subtraction angiography (DSA) is a technique for demonstrating the vasculature combining a rapid two-dimensional T1-weighted sequence with a bolus injection of gadolinium. We attempted to determine its contribution to the diagnosis of intracranial meningiomas. METHODS AND PATIENTS: MR DSA was performed in 18 patients with meningioma as well as in 28 patients with other tumors. The findings were analyzed regarding demonstration of tumor stain and tumor-related vessels.
RESULTS: All meningiomas except one were visualized as a homogeneous and intense stain. Feeding arteries were visualized in 2 patients, and draining or abnormal veins in three. In 21 of the 28 patients with other tumors, tumor stains of varying degrees were demonstrated.
CONCLUSION: MR DSA can serve as an adjunct to routine MR imaging, because it enables assessment of the hemodynamics of meningiomas and facilitates its differential diagnosis from other tumors.

Entities:  

Mesh:

Year:  2003        PMID: 12714229     DOI: 10.1016/s0720-048x(02)00059-1

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  3 in total

1.  2D Thick-section MR digital subtraction angiography for the assessment of dural arteriovenous fistulas.

Authors:  N Horie; M Morikawa; N Kitigawa; K Tsutsumi; M Kaminogo; I Nagata
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

2.  Contrast-enhanced time-resolved 3-D MRA: applications in neurosurgery and interventional neuroradiology.

Authors:  Peter C Reinacher; Paul Stracke; Marcus H T Reinges; Franz J Hans; Timo Krings
Journal:  Neuroradiology       Date:  2007-07       Impact factor: 2.804

3.  Clinical value of multi-slice 3-dimensional computed tomographic angiography in the preoperative assessment of meningioma.

Authors:  Xin Zhao; Ru-Tong Yu; Jiang-Shan Li; Kai Xu; Xiang Li
Journal:  Exp Ther Med       Date:  2013-06-06       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.